Fiche centre
Universitätsklinikum Mannheim
Mannheim — Germany
Essais liés2clinical trials
VilleMannheimlocalisation
PaysGermanylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04971005
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Autologous Hematopoietic Stem Cell Transplantation | SEP | Phase 2 | NCT04971005 | COAST — Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled Trial | TERMINATED |
| Ocrelizumab | SEP | À vérifier | NCT06780150 | SurfSubQ — A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS) | RECRUITING |